Weiyu Liu1,2, Yong Cao1, Yadi Guan1, Changqing Zheng3. 1. Department of Gastroenterology, Shengjing Hospital of China Medical University, 39 Huaxiang Road, Shenyang, 110022, People's Republic of China. 2. Department of Gastroenterology, The People's Hospital of Liaoning Province, Shenyang, 110013, People's Republic of China. 3. Department of Gastroenterology, Shengjing Hospital of China Medical University, 39 Huaxiang Road, Shenyang, 110022, People's Republic of China. zhengchangqing88@163.com.
Abstract
OBJECTIVES: To investigate the functional roles of bone marrow stromal cell antigen 2 (BST2) in gastric cancer (GC) cells and its implications in the development of GC patients. RESULTS: BST2 was frequently overexpressed in GC tissues compared with the adjacent non-tumorous tissues, and high BST2 expression was correlated with tumor stage and lymphatic metastasis. Furthermore, in vitro experiments demonstrated that knockdown of BST2 by siRNA inhibited cell proliferation, induced apoptosis and repressed cell motility in GC cells. In addition, the pro-tumor function of BST2 in GC was mediated partly through the NF-κB signaling. CONCLUSION: BST2 possesses the oncogenic potential in GC by regulating the proliferation, apoptosis, and migratory ability of GC cells, thereby BST2 could be a potential therapeutic target for the treatment of GC.
OBJECTIVES: To investigate the functional roles of bone marrow stromal cell antigen 2 (BST2) in gastric cancer (GC) cells and its implications in the development of GC patients. RESULTS:BST2 was frequently overexpressed in GC tissues compared with the adjacent non-tumorous tissues, and high BST2 expression was correlated with tumor stage and lymphatic metastasis. Furthermore, in vitro experiments demonstrated that knockdown of BST2 by siRNA inhibited cell proliferation, induced apoptosis and repressed cell motility in GC cells. In addition, the pro-tumor function of BST2 in GC was mediated partly through the NF-κB signaling. CONCLUSION:BST2 possesses the oncogenic potential in GC by regulating the proliferation, apoptosis, and migratory ability of GC cells, thereby BST2 could be a potential therapeutic target for the treatment of GC.
Authors: Tatjana Sauerer; Christopher Lischer; Adrian Weich; Carola Berking; Julio Vera; Jan Dörrie Journal: Front Microbiol Date: 2021-12-22 Impact factor: 5.640
Authors: Marcus A Florez; Katie A Matatall; Youngjae Jeong; Laura Ortinau; Paul W Shafer; Anne M Lynch; Roman Jaksik; Marek Kimmel; Dongsu Park; Katherine Y King Journal: Cell Rep Date: 2020-12-22 Impact factor: 9.423
Authors: Leah McNally; Yan Zhou; Joshua F Robinson; Guangfeng Zhao; Lee-May Chen; Hao Chen; M Yvonne Kim; Mirhan Kapidzic; Matthew Gormley; Roberta Hannibal; Susan J Fisher Journal: Proc Natl Acad Sci U S A Date: 2020-06-23 Impact factor: 11.205